Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR00477
|
|||||
| Drug Name |
Miconazole
|
|||||
| Synonyms |
(+-)-1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole; 1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole; 1-(2,4-dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl) imidazole; 1-[2,4-Dichloro-beta-([2,4-dichloro-benzyl]oxy)phenethyl]imidazole; 1-[2-(2,4-Dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]-1H-imidazole; 1-[2-(2,4-dichlorobenzyloxy)-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole; 1-[2-(2,4-dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]imidazole; 1-[2-(2,4-dichlorophenyl)-2-{[(2,4-dichlorophenyl)methyl]oxy}ethyl]-1H-imidazole; 1-{2-[(2,4-dichlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethyl}-1H-imidazole; Aflorix(nitrate); Albistat(nitrate); Andergin(nitrate); Conofite(nitrate); Dactarin; Daktarin (TN); Daktarin IV; Epi-Monistat(nitrate); Femizol (TN); Femizol-M; Florid(nitrate); Gyno-Daktar(nitrate); Imidazole, 1-(2-(2,4-dichlorophenyl)-2-((2,4-dichlorophenyl) methoxy)ethyl)-(9CI); Imidazole, 1-(2-(2,4-dichlorophenyl)-2-((2,4-dichlorophenyl)methoxy)ethyl)-(9CI); Lotrimin AF(nitrate); MCZ; MJR 1762; Micantin (nitrate); Micatin (TN); Miconasil Nitrate; Miconazex (TN); Miconazol; Miconazol [INN-Spanish]; Miconazole (JP15/USP/INN); Miconazole 3; Miconazole 3 Combination Pack; Miconazole 7 Combination Pack; Miconazole [USAN:BAN:INN:JAN]; Miconazole nitrate salt; Miconazole-7; Miconazolo; Miconazolo [DCIT]; Miconazolum; Miconazolum [INN-Latin]; Micozole; Minostate; Monazole 7; Monista (nitrate); Monistat; Monistat (TN); Monistat 1 Combination Pack; Monistat 3 Dual-Pak; Monistat 3 Vaginal Ovules; Monistat 5 Tampon; Monistat 7 Dual-Pak; Monistat 7 Vaginal Suppositories; Monistat Dual-PAK; Monistat IV; Monistat iv (TN); Monistat-Derm; Monistat-Derm (TN); Novo-Miconazole Vaginal Ovules; R 18134; R-14,889; Vusion; Zimycan
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Therapeutic Class |
Antifungal Agents
|
|||||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C18H14Cl4N2O
|
|||||
| Canonical SMILES |
C1=CC(=C(C=C1Cl)Cl)COC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl
|
|||||
| InChI |
InChI=1S/C18H14Cl4N2O/c19-13-2-1-12(16(21)7-13)10-25-18(9-24-6-5-23-11-24)15-4-3-14(20)8-17(15)22/h1-8,11,18H,9-10H2
|
|||||
| InChIKey |
BYBLEWFAAKGYCD-UHFFFAOYSA-N
|
|||||
| CAS Number |
CAS 22916-47-8
|
|||||
| Pharmaceutical Properties | Molecular Weight | 416.1 | Topological Polar Surface Area | 27 | ||
| Heavy Atom Count | 25 | Rotatable Bond Count | 6 | |||
| Hydrogen Bond Donor Count | 0 | Hydrogen Bond Acceptor Count | 2 | |||
| XLogP |
5.3
|
|||||
| PubChem CID | ||||||
| PubChem SID |
10321394
,10514422
,11112680
,11335331
,11360570
,11363859
,11366421
,11368983
,11371633
,11373720
,11377145
,11405748
,11405775
,11461542
,11466095
,11467215
,11484712
,11485910
,11488864
,11490323
,11491876
,11494779
,14806704
,25710691
,29223294
,443253
,46506017
,47365044
,47588856
,47736333
,47810615
,47885276
,48034973
,48259081
,48259082
,48416278
,49698872
,49979412
,5025447
,53789980
,53801024
,56310764
,56311695
,56312816
,56313686
,602748
,7847482
,7979986
,8152620
,853814
|
|||||
| ChEBI ID |
ChEBI:6923
|
|||||
| TTD Drug ID | ||||||
If you find any error in data or bug in web service, please kindly report it to Dr. Li and Dr. Fu.